Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Otsuka's 2012 sales performance.


Deal Watch February 2016

Deal Watch February 2016 AstraZeneca, Sanofi and Otsuka divested or out-licensed rights to products in certain territories. ... Otsuka Pharmaceutical/ Medimetriks Pharmaceuticals. OPA-15406, topical PDE-4 inhibitor for the treatment of atopic dermatitis (pII).

Rare disease therapies head the ‘class of 2015’

Rare disease therapies head the ‘class of 2015’ Rexulti. depression/schizophrenia. serotonin 5-HT1a / dopamine D2 partial agonist. Otsuka/Lundbeck. USA. ... Baxalta. USA. vonoprazan fumarate. Takecab. acid-related diseases. potassium-competitive acid blocker. Takeda/Otsuka.

FDA approves Alkermes’ long-acting Abilify

FDA approves Alkermes’ long-acting Abilify Abilify (aripiprazole) was originally developed by Otsuka Pharmaceuticals, but earlier this year was approved as a generic after a federal judge denied the company further exclusivity for the medication. ... The approval of Aristada will come as further

Axovant takes Alzheimer's drug into phase III

Axovant takes Alzheimer's drug into phase III Lundbeck and Otsuka also have a 5-HT6 antagonist called idalopirdine (Lu AE58054) in phase III trials that are due to report data between November and mid-2016.

Proteus: Digital medicines set to transform healthcare

Proteus: Digital medicines set to transform healthcare Earlier this month the company marked a key milestone when US regulator the FDA accepted its joint new drug application with Tokyo-based Otsuka Pharmaceuticals. ... The companies submitted for approval a sensor-enabled version of Otsuka's Abilify

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...